Cytura Therapeutics
1 known investors
Cytura Therapeutics develops cancer treatments that target genomic instability, both as a stand-alone therapy and in combination therapy, to reduce therapy resistance and relapse. The company operates in the oncology-focused biotech space, aiming to make cancer treatment more effective for patients.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Cytura Therapeutics do?
- Cytura Therapeutics develops cancer treatments that target genomic instability, both as a stand-alone therapy and in combination therapy, to reduce therapy resistance and relapse. The company operates in the oncology-focused biotech space, aiming to make cancer treatment more effective for patients.
- Who are Cytura Therapeutics's investors?
- Cytura Therapeutics's investors include BOM.